02096.HK
Simcere Pharmaceutical Group Limited
HKSE · Healthcare · Biotechnology · CN
HKD 11.63
−1.19%Margins
Gross margin
82.0%
EBITDA margin
22.4%
EBIT margin
18.1%
Net margin
15.5%
FCF margin
7.3%
25.9%
Return on equity
15.8%
Return on assets
26.8%
Return on invested capital
1.04x
Asset turnover
HKD 2.3B
Cash from operations
HKD 1.88
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026